Clinical Trial Update: Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of bazedoxifene/conjugated estrogens in postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Hyperplasia
• Osteoporosis

Drugs mentioned

• Duavee (bazedoxifene/conjugated estrogens) (bazedoxifene/conjugated estrogens)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Endometrial Hyperplasia, Osteoporosis | Phase 3 | Status: COMPLETED